Green Cures Valuation
| GRCU Stock | USD 0.0001 0.0001 50.00% |
Green Cures seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Green Cures Botanical from evaluating the firm fundamentals such as Return On Equity of 0.55, return on asset of 0.023, and Current Valuation of 4.85 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Green Cures' price fluctuation is out of control at this time. Calculation of the real value of Green Cures Botanical is based on 3 months time horizon. Increasing Green Cures' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Green Cures' intrinsic value may or may not be the same as its current market price of 0.0001, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.1E-5 | Hype 9.0E-5 |
The intrinsic value of Green Cures' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Green Cures' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Green Cures Botanical helps investors to forecast how Green pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Green Cures more accurately as focusing exclusively on Green Cures' fundamentals will not take into account other important factors: Green Cures Total Value Analysis
Green Cures Botanical is currently forecasted to have valuation of 4.85 M with market capitalization of 2.54 M, debt of 3.1 M, and cash on hands of 80 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Green Cures fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.85 M | 2.54 M | 3.1 M | 80 K |
Green Cures Investor Information
The company had not issued any dividends in recent years. Green Cures Botanical had 1:130 split on the 8th of January 2016. Based on the key indicators related to Green Cures' liquidity, profitability, solvency, and operating efficiency, Green Cures Botanical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Green Cures Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Green Cures has an asset utilization ratio of 3243.84 percent. This implies that the Company is making $32.44 for each dollar of assets. An increasing asset utilization means that Green Cures Botanical is more efficient with each dollar of assets it utilizes for everyday operations.Green Cures Profitability Analysis
The company reported the previous year's revenue of 13.17 K. Net Loss for the year was (1.09 M) with profit before overhead, payroll, taxes, and interest of 989.6 K.About Green Cures Valuation
The pink sheet valuation mechanism determines Green Cures' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Green Cures Botanical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Green Cures. We calculate exposure to Green Cures's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Green Cures's related companies.Green Cures Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. Green Cures Botanical Distribution Inc. is based in Inglewood, California. Green Cures operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 20 people.
8 Steps to conduct Green Cures' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Green Cures' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Green Cures' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Green Cures' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Green Cures' revenue streams: Identify Green Cures' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Green Cures' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Green Cures' growth potential: Evaluate Green Cures' management, business model, and growth potential.
- Determine Green Cures' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Green Cures' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Green Cures Growth Indicators
Investing in growth stocks can be very risky. If the company such as Green Cures does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Price Earnings Ratio | 0.0002 | |
| Retained Earnings | -1.5 M | |
| Trailing Price Earnings | 0.0002 |
Additional Tools for Green Pink Sheet Analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.